IRIS UniCatt

Innocenti, Idanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.799
AS - Asia 4.181
EU - Europa 3.142
SA - Sud America 917
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 13.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.685
SG - Singapore 1.858
CN - Cina 1.046
BR - Brasile 743
SE - Svezia 635
IT - Italia 606
DE - Germania 542
VN - Vietnam 453
FR - Francia 377
IE - Irlanda 181
IN - India 172
GB - Regno Unito 162
FI - Finlandia 156
UA - Ucraina 136
ID - Indonesia 130
JP - Giappone 112
RU - Federazione Russa 92
HK - Hong Kong 77
PL - Polonia 69
AR - Argentina 68
BD - Bangladesh 68
CA - Canada 51
TR - Turchia 45
MX - Messico 42
IQ - Iraq 36
KR - Corea 35
EC - Ecuador 30
NL - Olanda 30
AT - Austria 28
CI - Costa d'Avorio 27
ES - Italia 25
BE - Belgio 24
ZA - Sudafrica 21
PK - Pakistan 18
CO - Colombia 17
UZ - Uzbekistan 17
VE - Venezuela 17
MA - Marocco 15
PY - Paraguay 15
CZ - Repubblica Ceca 13
IL - Israele 12
IR - Iran 12
SA - Arabia Saudita 12
CL - Cile 11
CH - Svizzera 10
DZ - Algeria 9
EG - Egitto 9
KE - Kenya 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
TN - Tunisia 8
BG - Bulgaria 7
BO - Bolivia 7
KZ - Kazakistan 7
GR - Grecia 6
JO - Giordania 6
OM - Oman 6
LT - Lituania 5
PT - Portogallo 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
HU - Ungheria 4
KW - Kuwait 4
LK - Sri Lanka 4
NP - Nepal 4
PE - Perù 4
QA - Qatar 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
KH - Cambogia 3
LB - Libano 3
NI - Nicaragua 3
UY - Uruguay 3
AU - Australia 2
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
DK - Danimarca 2
GY - Guiana 2
HN - Honduras 2
LU - Lussemburgo 2
RS - Serbia 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
EE - Estonia 1
Totale 13.142
Salva come PNG Salva come JPEG
Città #
Singapore 923
Chandler 666
San Jose 491
Ashburn 449
Beijing 239
Dublin 176
Rome 156
Ho Chi Minh City 143
Lauterbourg 133
Los Angeles 123
Jakarta 117
Hanoi 114
Dearborn 112
Hefei 108
New York 104
Jacksonville 103
San Mateo 103
Tokyo 98
Wilmington 96
Ann Arbor 93
Council Bluffs 89
Frankfurt am Main 82
Munich 79
Cattolica 76
Nanjing 73
Boston 71
Chicago 71
Hyderabad 70
Dallas 69
Hong Kong 68
Milan 65
Warsaw 64
Florence 62
Marseille 61
Princeton 61
Helsinki 58
Fairfield 55
São Paulo 53
Woodbridge 50
Moscow 49
Houston 48
Buffalo 47
Lancaster 46
Nanchang 39
Seattle 39
Bremen 35
Lappeenranta 34
Orem 33
Seoul 33
The Dalles 33
Santa Clara 32
Lawrence 30
Turku 30
Rio de Janeiro 28
Abidjan 27
Kunming 27
Shanghai 27
Kent 26
Brooklyn 25
Redwood City 25
Brussels 24
Paris 23
Shenyang 23
Tianjin 23
Boardman 21
Cambridge 21
Stockholm 21
Da Nang 20
London 20
Nuremberg 18
Atlanta 17
Düsseldorf 17
Izmir 17
Minneapolis 17
Phoenix 17
Redmond 17
Tashkent 17
Vienna 17
Albany 16
Mexico City 16
St Louis 16
Biên Hòa 15
Guangzhou 15
Johannesburg 15
Naples 15
Pune 15
Washington 15
Zhengzhou 15
Dhaka 14
Haiphong 14
Norwalk 14
Nürnberg 14
Tampa 14
Auburn Hills 13
Baghdad 13
Denver 13
Elk Grove Village 13
Mountain View 13
Salt Lake City 13
Toronto 13
Totale 7.201
Salva come PNG Salva come JPEG
Nome #
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 332
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 209
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR 208
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 186
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 177
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 175
Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids. 168
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 168
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 164
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 163
Role of microRNAs in Chronic Lymphocytic Leukemia 157
The effects of omega-3 polyunsaturated fatty acids against cancer 156
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 149
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 148
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 147
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 143
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 141
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 141
Mycosis fungoides as a cause of severe obstructive sleep apnea 137
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 136
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 132
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 129
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 126
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 123
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma 122
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 121
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 121
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 120
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 119
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients 118
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 116
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 116
Unrelated cord blood transplantation and post-transplant cyclophosphamide 115
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 111
the concomitance of lymphoma and breast carcinoma in the bone 111
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 111
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 110
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. 109
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 109
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 106
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 105
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 105
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 104
Second haploidentical stem cell transplantation for primary graft failure 104
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 103
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 102
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 102
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia 101
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 100
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 99
Richter transformation in Chronic Lymphocytic Leukemia 99
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 99
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 99
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 99
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 98
Chronic Lymphocitic Leukaemia: Census of Patients Treated in Italian Haematology Units 97
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 97
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 97
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 97
CD49d promotes disease progression in chronic lymphocytic leukemia: New insights from CD49d bimodal expression 97
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 95
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 95
Unrelated cord blood transplantation and post-transplant cyclophosphamide 95
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 95
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 94
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia 93
Validation of the CLL-IPI and comparison with the MDACC prognostic index: analysis of 1364 newly diagnosed patients 92
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 91
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 89
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 89
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 89
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 88
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 88
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 88
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 88
The concomitance of lymphoma and breast carcinoma in the bone 88
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation 88
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 88
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 88
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed 87
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia 86
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 85
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature 85
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 83
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 83
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 83
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab 82
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 82
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 81
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 80
Second haploidentical stem cell transplantation for primary graft failure 80
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 79
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 79
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 79
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 78
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 78
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 76
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 76
Totale 11.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 75 8
2021/2022763 61 27 27 38 56 14 9 115 31 40 182 163
2022/20231.857 254 250 133 259 145 238 107 137 208 43 64 19
2023/20241.010 45 268 63 64 41 147 69 34 18 42 106 113
2024/20252.227 49 69 145 77 179 68 67 87 271 259 577 379
2025/20265.432 805 199 386 689 895 328 943 339 412 422 14 0
Totale 13.396